The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial

The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial

Abstract Background By 2050, the prevalence of Alzheimer’s disease (AD) in the United States is predicted to reach 13.8 million. Despite worldwide research efforts, a cure for AD has not been identified. Thus, it is critical to identify preventive strategies that can reduce the risk of or delay the...

Full description

Bibliographic Details
Main Authors: Kyoung Shin Park, Alexis B. Ganesh, Nathaniel T. Berry, Yashonda P. Mobley, William B. Karper, Jeffrey D. Labban, Christopher N. Wahlheim, Tomika M. Williams, Laurie Wideman, Jennifer L. Etnier
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Neurology
Subjects:
Alzheimer’s disease
Apolipoprotein
BDNF
Dementia
Episodic memory
Executive function
Online Access:http://link.springer.com/article/10.1186/s12883-020-01732-1

Internet

http://link.springer.com/article/10.1186/s12883-020-01732-1

Similar Items